Screening women for Chlamydia trachomatis in family planning clinics: The cost-effectiveness of DNA amplification assays

Sexually Transmitted Diseases

Volumn 25, Issue 2, 1998, Pages 108-117

  Howell, M René ^a   Quinn, Thomas C ^a,b   Brathwaite, Wayne ^c   Gaydos, Charlotte A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c BALTIMORE CITY HEALTH DEPARTMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOXYCYCLINE;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DNA DETERMINATION; FAMILY PLANNING; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; SCREENING TEST;

ADULT; AMBULATORY CARE FACILITIES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COST-BENEFIT ANALYSIS; DECISION MAKING, COMPUTER-ASSISTED; DNA PROBES; FAMILY PLANNING SERVICES; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MASS SCREENING; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0031910615     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199802000-00008     Document Type: Article

References (43)

1. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections. MMWR 1993; 42:1-39.
2. Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease: Trends and projections, 1983 through 2000. JAMA 1991; 266:2565-2569.
3. Bass CA, Jungkind DL, Silverman NS, Bondi JM. Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol 1993; 31:2648-2653.
4. Blanchi A, Scieux C, Brunat N, et al. An evaluation of the polymerase chain reaction Amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis 1994; 21:196-200.
5. Catry M, Borrego MJ, Cardos J, Azevedo J, Santo I. Comparison of the Amplicor Chlamydia trachomatis test and cell culture for the detection of urogenital chlamydial infections. Genitourin Med 1995; 71:247-250.
6. Mahony JB, Luinstra KE, Sellors JW, et al. Role of confirmatory PCRs in determining performance of chlamydia Amplicor PCR with endocervical specimens from women with a low prevalence of infection. J Clin Microbiol 1994; 32:2490-2493.
7. Quinn TC, Welsh L, Lentz A, et al. Diagnosis by Amplicor PCR for Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics. J Clin Microbiol 1996; 34:1401-1406.
8. Skulnick M, Chua R, Simor AE, et al. Use of PCR for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low prevalence population of women. Diagn Microbiol Infect Dis 1994; 20:195-201.
9. van Doornum GJJ, Buimer M, Prins M, et al. Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction. J Clin Microbiol 1995; 33:2042-2047.
10. Schachter J, Stamm WE, Quinn TC, Andrews WW, Burczak JD, Lee HH. Ligase chain reaction (LCR) to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol 1994; 32:2540-2543.
11. Buimer G, VanDoomum G, Ching P, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: Implications for diagnostic testing and screening. J Clin Microbiol 1996; 34:2395-2400.
12. Bassin M, Hu HY, Domeika MA, et al. Detection of Chlamydia trachomatis in urine specimens from women by ligase chain reaction. J Clin Microbiol 1995; 33:898-900.
13. Chernesky MA, Jang D, Lee H, et al. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol 1994; 32:2682-2685.
14. Lee HH, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995; 345(i):213-216.
15. Schachter J, Moncada J, Whidden R, Shaw H, Bolan G, Burczak JD. Noninvasive tests for diagnosis of Chlamydia trachomatis infection: Application of ligase chain reaction to first-catch urine specimens of women. J Infect Dis 1995; 172:1411-1414.
16. Schachter J, Stamm WE, Chernesky MA, et al. Nonculture tests for genital tract chlamydial infection: What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis 1992; 19:243-244.
17. Blanding J, Hirsch L, Stranton N, et al. Comparison of the Clearview Chlamydia, the PACE 2 assay, and culture for detection of Chlamydia trachomatis from cervical specimens in a low prevalence population. J Clin Microbiol 1993; 31:1622-1625.
18. Clarke L, Sierra M, Daidone B, Lopez N, Covino J, McCormack W. Comparison of the Syva Microtrak enzyme immunoassay and GenProbe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population. J Clin Microbiol 1993; 31:968-971.
19. Gaydos CA, Reichart CA, Long JM, et al. Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens. J Clin Microbiol 1990; 28:1541-1544.
20. Hosien IK, Kaunitz AM, Draft SJ. Detection of cervical Chlamydia trachomatis and Neisseria gonorrhoeae with deoxyribonucleic acid probe assays in obstetric patients. Am J Obstet Gynecol 1992; 197:588-591.
21. Limberger RJ, Biega R, Evancoe A, McCarthy L, Slivienski L, Kirkwood M. Evaluation of culture and the Gen-Probe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory. J Clin Microbiol 1992; 30:1162-1166.
22. Pasternack R, Vuorinen R, Kuukankorpi A, Pitkajarvi T, Miettinen A. Detection of Chlamydia trachomatis infections in women by Amplicor PCR: Comparison of diagnostic performance with urine and cervical specimens. J Clin Microbiol 1996; 34:995-998.
23. Thejils H, Gnarpe J, Gnarpe H, et al. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: Diagnostic efficacy of tissue culture, DFA, EIA, PCR and serology. Genitourin Med 1994; 70:300-303.
24. Warren R, Dwyer B, Plackett M, Pettit K, Rizvi N, Baker A. Comparative evaluation of detection assays for Chlamydia trachomatis. J Clin Microbiol 1993; 31:1663-1666.
25. Bauwens JE, Clark AM, Stamm WE. Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol 1993; 31:3023-3027.
26. Hillis SD, Berlin M, Berlin JA, et al. Targeting screening for chlamydial infections in women: Is young age enough [Abstract]? In: Eleventh Meeting of the International Society for STD Research, New Orleans, LA, 1995; 267:156.
27. Hook EW, Spitters C, Reichart CA, Neuman TM, Quinn TC. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA 1994; 272:867-870.
28. Magid D, Douglas JM, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: An incremental cost-effectiveness analysis. Ann Intern Med 1996; 124:389-399.
29. Jones RB, Mammel JB, Shepard M, Risher RR. Recovery of Chlamydia trachomatis from the endometrium of women at risk for chlamydial infection. Am J Obstet Gynecol 1986; 155:35-39.
30. Rees E. The treatment of pelvic inflammatory disease. Am J Obstet Gynecol 1980; 138:1042.
31. Stamm WE, Guinan ME, Johnson C, Starcher T, Holmes KK, McCormack WM. Effect of treatment regimes for Neisseria gonorrhea on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984; 310:545-549.
32. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy. Sex Transm Dis 1997; 24:131-141.
33. Haddix AC, Hillis SD, Kassler WJ. The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sex Transm Dis 1995; 22:274-280.
34. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-192.
35. Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276:1737-1742.
36. Stamm WE, Cole B. Asymptomatic Chlamydia trachomatis urethritis in men. Sex Transm Dis 1986; 13:163-165.
37. Washington AE, Johnson RE, Sanders LL. Chlamydia trachomatis infections in the United States: What are they costing us? JAMA 1987; 257:2070-2072.
38. Schachter J, Grossman M, Sweet RL, Holt J, Jordan C, Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986; 255:3374-3377.
39. Hammerschlag MR, Anderlea M, Semine DZ, McComb D, McCormack WM. Prospective study of maternal and infertile infection with Chlamydia trachomatis. Pediatrics 1979; 64:142-148.
40. Begley CE, McGill L, Smith PB. The incremental cost of screening, diagnosis and treatment of gonorrhea and chlamydia in a family planning clinic. Sex Transm Dis 1989; 16:63-67.
41. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362-1366.
42. Tenga TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis 1995; 13:369-390.
43. Stika C, Anderson L, Frederiksen M. Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three year experience. Am J Obstet Gynecol 1996; 174:1840-1846.